73 related articles for article (PubMed ID: 27779713)
1. A novel blood-pooling MR contrast agent: Carboxymethyl-diethylaminoethyl dextran magnetite.
Sonoda A; Nitta N; Tsuchiya K; Nitta-Seko A; Ohta S; Otani H; Murata K
Mol Med Rep; 2016 Dec; 14(6):5195-5198. PubMed ID: 27779713
[TBL] [Abstract][Full Text] [Related]
2. Negatively charged superparamagnetic iron oxide nanoparticles: a new blood-pooling magnetic resonance contrast agent.
Nitta N; Tsuchiya K; Sonoda A; Ota S; Ushio N; Takahashi M; Murata K; Nohara S
Jpn J Radiol; 2012 Dec; 30(10):832-9. PubMed ID: 23001374
[TBL] [Abstract][Full Text] [Related]
3. Dual-energy CT imaging of atherosclerotic plaque using novel ultrasmall superparamagnetic iron oxide in hyperlipidemic rabbits.
Sato H; Fujimoto S; Kawaguchi YO; Nozaki YO; Tomizawa N; Kogure Y; Minamino T
Acta Radiol; 2023 Apr; 64(4):1718-1724. PubMed ID: 36226361
[TBL] [Abstract][Full Text] [Related]
4. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Neuwelt EA; Hamilton BE; Varallyay CG; Rooney WR; Edelman RD; Jacobs PM; Watnick SG
Kidney Int; 2009 Mar; 75(5):465-74. PubMed ID: 18843256
[TBL] [Abstract][Full Text] [Related]
6. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
Schnorr J; Taupitz M; Schellenberger EA; Warmuth C; Fahlenkamp UL; Wagner S; Kaufels N; Wagner M
Rofo; 2012 Feb; 184(2):105-12. PubMed ID: 22179768
[TBL] [Abstract][Full Text] [Related]
7. Specific E-selectin targeting with a superparamagnetic MRI contrast agent.
Boutry S; Laurent S; Elst LV; Muller RN
Contrast Media Mol Imaging; 2006; 1(1):15-22. PubMed ID: 17193596
[TBL] [Abstract][Full Text] [Related]
8. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
9. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
10. Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
Tourdias T; Roggerone S; Filippi M; Kanagaki M; Rovaris M; Miller DH; Petry KG; Brochet B; Pruvo JP; Radüe EW; Dousset V
Radiology; 2012 Jul; 264(1):225-33. PubMed ID: 22723563
[TBL] [Abstract][Full Text] [Related]
11. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
[TBL] [Abstract][Full Text] [Related]
12. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
13. Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent--experimental study in the rat.
Johansson L; Johnsson C; Penno E; Björnerud A; Ahlström H
Radiology; 2002 Oct; 225(1):97-103. PubMed ID: 12354991
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Macrophage Plaque Imaging Using Novel Ultrasmall Superparamagnetic Iron Oxide in Dual Energy CT.
Sato H; Fujimoto S; Kogure Y; Daida H
Eur J Radiol Open; 2018; 5():87-91. PubMed ID: 30069497
[TBL] [Abstract][Full Text] [Related]
15. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
Simon GH; von Vopelius-Feldt J; Wendland MF; Fu Y; Piontek G; Schlegel J; Chen MH; Daldrup-Link HE
J Magn Reson Imaging; 2006 May; 23(5):720-7. PubMed ID: 16557494
[TBL] [Abstract][Full Text] [Related]
16. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model.
Choi SH; Kim KH; Moon WK; Kim HC; Cha JH; Paik JH; Chang KH
J Magn Reson Imaging; 2010 Jan; 31(1):134-41. PubMed ID: 20027581
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG
J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance enhancement features of inflammatory lymph nodes with ultrasmall superparamagnetic iron oxide in rabbit model].
Lei J; Xue HD; Li S; Li Z; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):182-6. PubMed ID: 19507597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
